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Abstract 
Background: Babies born weighing ≥ 2500 g account for more than 80% of the births in most resource‑limited 
locations and for nearly 50% of the 28‑day neonatal deaths. In contrast, in high‑resource settings, 28‑day neonatal 
mortality among this group represents only a small fraction of the neonatal deaths. Yet mortality risks for birth weight 
of ≥ 2500 g is limited. Knowledge regarding the factors associated with mortality in these babies will help in identify‑
ing interventions that can reduce mortality.
Methods: The Global Network’s Maternal Newborn Health Registry (MNHR) is a prospective, population‑based 
observational study that includes all pregnant women and their pregnancy outcomes in defined geographic com‑
munities that has been conducted in research sites in six low‑middle income countries (India, Pakistan, Democratic 
Republic of Congo, Guatemala, Kenya and Zambia). Study staff enroll all pregnant women as early as possible during 
pregnancy and conduct follow‑up visits to ascertain delivery and 28‑day neonatal outcomes. We analyzed the neona‑
tal mortality rates (NMR) and risk factors for deaths by 28 days among all live‑born babies with a birthweight ≥ 2500 g 
from 2010 to 2018 across the Global Network sites.
Results: Babies born in the Global Network sites from 2010 to 2018 with a birthweight ≥ 2500 g accounted for 84.8% 
of the births and 45.4% of the 28‑day neonatal deaths. Among this group, the overall NMR was 13.1/1000 live births. 
The overall 28‑day NMR for ongoing clusters was highest in Pakistan (29.7/1000 live births) and lowest in the Zam‑
bian/Kenyan sites (9.3/1000) for ≥ 2500 g infants. ≥ 2500 g NMRs declined for Zambia/Kenya and India. For Pakistan 
and Guatemala, the NMR remained almost unchanged over the period. The ≥ 2500 g risks related to maternal, delivery 
and newborn characteristics varied by site. Maternal factors that increased risk and were common for all sites included 
nulliparity, hypertensive disease, previous stillbirth, maternal death, obstructed labor, severe postpartum hemor‑
rhage, and abnormal fetal presentation. Neonatal characteristics including resuscitation, hospitalization, congenital 
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Background
The World Health Organization (WHO) defines a neona-
tal death as the death of a live born infant during the first 
28 days of life. Of 5.7 million under-five deaths that occur 
annually, approximately 47% occur in the first 28 days [1]. 
Disparities in the 28-day neonatal mortality rate (NMR) 
exist across and within countries. The NMR is much 
higher in resource constrained countries than in well-
resourced countries, although exceptions exist [2]. Babies 
with a birthweight ≥ 2500 g account for more than 80% of 
the births in most resource limited locations, and often 
account for nearly half of the neonatal deaths [3]. Because 
of the continuing focus on preterm and low-birthweight 
births, which are higher risk but account for only about 
half the neonatal deaths, information on mortality for 
babies born with a birth weight of ≥ 2500  g is limited. 
Knowledge regarding the trends and factors associated 
with mortality in these babies will help in identifying 
interventions that can result in lower mortality.
In many high-resource settings, substantial improve-
ments have been made in neonatal outcomes, with 
deaths in babies with a birth weight of ≥ 2500 g substan-
tially reduced [3]. For example, in 2015 in Europe, 94%–
95% of births were ≥ 2500  g and these births accounted 
for 24% of the neonatal mortality [4]. In low-resource set-
tings, the mortality among these infants is still substan-
tially higher than observed in high-resource settings [2, 
5]. Thus, while infants born < 2500 g have a higher risk of 
neonatal mortality compared to those ≥ 2500 g, because 
most of the births are ≥ 2500  g, these births potentially 
represent a large proportion of the potentially prevent-
able deaths in low-resource settings [6].
The Maternal Newborn Health Registry (MNHR) of 
the Global Network for Women’s and Children’s Health 
Research (Global Network) is a pregnancy registry con-
ducted in sites in low-resource countries in south Asia, 
sub-Saharan Africa and Central America [7, 8]. The 
MNHR data demonstrates high neonatal mortality rates 
across the participating surveillance sites of member 
countries [8–10]. Overall, the MNHR data show slowly 
improving but continuing high maternal and neonatal 
mortality rates over the years across all Global Network 
sites [10]. We sought to explore the trends and factors 
associated with mortality in babies born with a birth 
weight of ≥ 2500  g. These infants are generally term or 
late preterm and the overwhelming majority can survive 
with usual obstetric and newborn care.
Methods
The Global Network’s MNHR is a prospective, popula-
tion-based observational study that includes all preg-
nant women and their outcomes in defined geographic 
communities (clusters) [7, 8]. In these clusters there are 
approximately 300 to 500 births annually. There are cur-
rently 8–10 clusters at each of the sites in western Kenya, 
Zambia (Kafue and Chongwe), the Democratic Republic 
of the Congo (DRC) (North and South Ubangi Province), 
Pakistan (Thatta in Sindh Provence), India (Belagavi and 
Nagpur) and Guatemala (Chimaltenango). The MNHR 
was initiated at each of the study sites between 2008 and 
2009, except for the DRC, which joined the Global Net-
work in 2014.
Registry administrators (RAs) are generally paid com-
munity health workers or nurses who identify pregnant 
women in their respective areas and after consent, 
enroll them in the MNHR. Once a pregnant woman is 
identified, the RAs obtain basic health information at 
enrollment, record the date of last menstrual period or 
early ultrasound report to assess gestational age, obtain 
a hemoglobin assessment where possible, and record 
the height and weight of the pregnant woman. A fol-
low-up visit is carried out following delivery to collect 
information on pregnancy outcomes as well as health 
care received during delivery. Information on the study 
outcomes is based on medical record reviews and birth 
attendant and family interviews. Birth weights for 
babies born in hospitals are available from the birth 
certificates or hospital records and for home deliver-
ies, babies are weighed within 48 h of birth by the RAs 
using study scales. Where birth weights could not be 
obtained by scale, the weight was estimated to distin-
guish infants < 1500  g and < 2500  g. Only 0.4% of the 
anomalies and male sex, as well as lower gestational ages and birthweights were also associated with increased 
mortality.
Conclusions: Nearly half of neonatal deaths in the Global Network sites occurred in infants born weighing ≥ 2500 g. 
The NMR for those infants was 13.1 per 1000 live births, much higher than rates usually seen in high‑income coun‑
tries. The changes in NMR over time varied across the sites. Even among babies born ≥ 2500 g, lower gestational 
age and birthweight were largely associated with increased risk of mortality. Since many of these deaths should be 
preventable, attention to preventing mortality in these infants should have an important impact on overall NMR.
Trial registration: https ://Clini calTr ials.gov Identifier: NCT01073475
Keywords: Neonatal mortality, ≥ 2500 g neonatal mortality, Low and middle‑income countries, Global network
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birthweights in ≥ 2500  g infants were estimated. The 
timing of neonatal death is defined by the day of death. 
Because gestational age estimation is often difficult in 
these settings, the Global Network developed an algo-
rithm to determine an estimate of preterm birth [7].
Statistical analyses
For analyses, we combined sites in the same region with 
similar outcomes. For example, the NMRs for Zambia 
and Kenya were similar so they were combined. The 
DRC data were not combined with the other African 
sites both because this site had a substantially higher 
NMR and the DRC did not have data available for 
2010–2013. Similarly, the NMRs for Nagpur and Bela-
gavi, India were similar and were combined, while the 
Pakistani site NMR was substantially higher. The Gua-
temala site was the only one in Central America.
We conducted analyses to determine the risk fac-
tors associated with NMR, defined as any death 
that occurred from day 0 through 27, among live 
births ≥ 2500  g. To assess the relationship between 
these characteristics and ≥ 2500  g mortality, log-bino-
mial models were used to obtain relative risk estimates 
for mortality modeled as a function of each character-
istic independently. Each model included site and the 
interaction between site and the characteristic of inter-
est in order to obtain site-specific relative risk estimates 
while controlling for the correlation of morality within 
clusters using generalized estimating equations.
Thus, this study analyzed NMR among babies born 
alive with a birth weight of ≥ 2500  g during the last 
9  years (2010–2018) across Global Network surveil-
lance sites and also describes the maternal, delivery and 
newborn characteristics associated with a higher risk of 
mortality in these infants.
Ethical approvals
This study was reviewed and approved by all sites’ eth-
ics review committees at INCAP, Guatemala; Univer-
sity of Zambia, Zambia; Moi University, Kenya; Aga 
Khan University, Pakistan; KLE University’s Jawaharlal 
Nehru Medical College, Belagavi, India; Lata Medical 
Research Foundation, Nagpur, India, and the Kinshasa 
School of Public Health, DRC. The institutional review 
boards at each U.S. partner university and the Data 
Coordinating Center (RTI International) also approved 
the protocol. All women provided informed consent for 
participation in the study, including data collection and 
the follow-up visits.
Results
From January 2010 through December 2018, 582,768 
women were screened and 579,140 (99.4%) women 
consented to participate in the study (Fig. 1). Of those 
consented, delivery status was obtained for 572,939 
women (98.9%) with 5992 lost to follow-up prior to 
delivery. There were 15,604 stillbirths, which were 
excluded from analyses. Altogether, 463,922 live births 
with a birth weight ≥ 2500 g were included in the study. 
Because several of the study clusters were discontinued 
over the course of the study period, and the DRC did 
not have data for all years, for analyses of trends over 
time, we restricted analyses to those clusters that were 
in the study for the entire period (N = 382,635).
Babies with a birth weight recorded as ≥ 2500  g 
accounted for 84.8% of the births in the Global Net-
work sites and 45.4% of the neonatal deaths. The overall 
NMR for ≥ 2500 g infants for all sites from 2010 to 2018 
was 13.1/1000 live births. Among clusters ongoing from 
2010 to 2018, the overall NMR was 12.8 and declined 
from 15.0/1000 live births in 2010 to 10.8/1000 in 2018. 
(Table 1). For the babies who died, 48.6% died on days 
0–1, 29.2% on days 2–6, 10.7% on days 7–13 and 11.5% 
on days 14–27.
Among ongoing clusters, the NMR for ≥ 2500  g 
infants was highest for the Pakistan site (29.7/1000 live 
births) and lowest for the Zambian/Kenyan sites (NMR 
9.3/1000 live births) (Table 1). The NMR in babies born 
alive with a birth weight of ≥ 2500 g declined from 2010 
to 2018 for the Zambia/Kenya sites from 13.4/1000 live 
births to 6.7/1000. The Indian sites had a decline in 
the ≥ 2500 g NMR from 11.8/1000 live births in 2010 to 
6.6 /1000 live births in 2018. The ≥ 2500 g NMR in the 
Pakistani, DRC and Guatemalan sites did not appear to 
change substantially over time (Fig. 2).
Table  2 presents the numbers and percent of the 
maternal characteristics of the ≥ 2500 infants by who 
died and who lived in each site by region, and Table 3 
describes the relative risk of maternal characteristics 
with neonatal death for infants born alive and with 
a ≥ 2500  g weight. In all sites, nulliparity was associ-
ated with a greater risk of ≥ 2500  g neonatal mortal-
ity as compared to women with 1–2 parity. The prior 
pregnancy ending in stillbirth was also associated with 
a higher risk of ≥ 2500 g neonatal mortality in all sites 
as was having a hypertensive disorder in pregnancy. In 
the DRC, although the numbers were small, ≥ 2500  g 
babies born to hypertensive mothers had a 17 times 
greater risk of dying, while at other sites the risk was 
more than twice compared to their counterparts. The 
risk for ≥ 2500 g neonatal mortality increased substan-
tially when a maternal death occurred before 42  days 
post-partum in all study sites.
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For Kenya/Zambia and DRC, mothers < 20  years of 
age were at higher risk for ≥ 2500  g neonatal mortality 
as compared to the mothers 20–35 year of age; however, 
this association was not observed for the sites in India, 
Pakistan, and Guatemala. Maternal age of more than 
35  years was associated with a higher risk of ≥ 2500  g 
neonatal mortality in sites in the DRC, Pakistan, and 
Guatemala only. For the Indian, Pakistani, and Guatema-
lan sites, a lack of formal education was associated with 
increased ≥ 2500 g neonatal mortality, but not in the Afri-
can region. Parity ≥ 3 was associated with an increased 
risk of ≥ 2500  g neonatal mortality in India, Pakistan, 
and Guatemala. The association between the number of 
antenatal care (ANC) visits and risk for ≥ 2500 g neona-
tal mortality varied by site. The risk of ≥ 2500 g neonatal 
mortality was higher in women who had a single ANC 
visit for Kenya/ Zambia but not for the other sites. As 
compared to women with ≥ 4 ANC visits, having no 
ANC doubled the risk of ≥ 2500 g neonatal mortality for 
women in the Guatemalan site, but was associated with 
reduced risk of neonatal death among Pakistani women. 
Two to three ANC visits were associated with higher risk 
for ≥ 2500  g neonatal mortality for the Indian sites but 
were associated with a 15% lower risk of neonatal death 
for the Pakistan site.
Table 4 presents the numbers and percent of the deliv-
ery characteristics of the ≥ 2500  g infants who died and 
lived in each site by region, and Table 5 describes the rel-
ative risk of delivery characteristics with neonatal death 
for infants born alive and with a ≥ 2500 g weight for each 
Delivered (N=572,939)
Excluded     
Miscarriages/MTP/loss (N=25,822)
Stillbirths                                      (N=15,604)
Birthweight < 2500 g  (N=71,369)
Unknown birth weight (N=124)
Births in the analyses
(N=463,922)
Eligible and Consented 
(N=579,140)
Screened (N=582,768)
Lost to follow-up before delivery (N=5,992)
Maternal death before delivery      (N=209)
)345,2=N(elbigilenI
Did not consent (N=1,085)
Births in the analyses from 
ongoing clusters
(N=382,635)
Fig. 1 Subject diagram
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site. Abnormal fetal presentation at the time of delivery 
and obstructed labor were associated with higher risk 
of ≥ 2500  g neonatal mortality at all the sites. (Table  5) 
Severe post-partum hemorrhage and unplanned hospital-
ization were also associated with higher risk of ≥ 2500 g 
neonatal mortality for all the participating sites except 
Guatemala. Compared to hospital deliveries, babies 
with a birth weight ≥ 2500  g who were born at a clinic 
or health center had a lower risk of mortality in Zambia/
Kenya, DRC and India; however, there was no difference 
in Pakistan and Guatemala. Home births were associated 
with higher risk of ≥ 2500 g NMR in the Indian sites, but 
associated with a 50% and 30% lower risk of NMR in the 
DRC and Pakistani sites, respectively. In the Guatemalan 
and Zambian/Kenyan sites, the risk of ≥ 2500  g neona-
tal mortality with home delivery compared to hospital 
delivery was similar. Except for Guatemala, assisted vac-
uum/forceps delivery was associated with a higher risk 
of ≥ 2500 g neonatal mortality. Similarly, cesarean deliv-
ery was associated with a higher risk of ≥ 2500 g neonatal 
mortality in Zambia/Kenya, DRC, and Pakistan, but not 
in India and Guatemala.
Table 6 presents the numbers and percent of the new-
born characteristics of the ≥ 2500  g infants who died 
and lived in each site by region, and Table  7 describes 
the relative risk of neonatal characteristics with neo-
natal death for infants born alive and with a ≥ 2500  g 
birthweight. Congenital anomalies were associated with 
adjusted relative risks of neonatal mortality in the vari-
ous sites ranging from 9.7 to 101.0 and appeared to be 
the strongest risk factor for neonatal death in nearly all 
sites (Table 7). The next strongest risk factor for neona-
tal mortality among the infant characteristics was the 
receipt of resuscitation at birth with relative risks ranging 
from 6.6 in Pakistan to 48.2 in the DRC. Neonatal hos-
pitalization was a significant risk factor in all sites with 
relative risks ranging from 10 in Zambia/Kenya to 66.4 
in India. Male gender was also associated with increased 
risk of neonatal death in ≥ 2500 g births in all sites. The 
risk for ≥ 2500 g neonatal mortality was also significantly 
increased among those classified as preterm compared to 
term for all sites except the DRC. As compared to babies 
with a birth weight of 3001 to 3500 g, babies born with a 
birth weight of 2500 to 2700 g had a higher risk of death 
in Zambia/Kenya, India, and Pakistan. This higher risk 
of death continued for babies born with a birth weight of 
2701 g to 3000 g for the Kenyan/Zambian and Pakistani 
sites. As compared to babies with a birth weight of 3001 
to 3500  g, babies with a birth weight ≥ 3500  g were at 
higher risk of death in the sites in Zambia/Kenya, DRC, 
Table 1 Neonatal mortality among infants ≥ 2500 g in the Global Network sites, 2010–2018
a The following rows present ≥ 2500 g neonatal mortality in the subset of MNH Registry clusters collecting data during the entire period (i.e. 2010–2018 for all sites 
besides DRC and 2014–2018 for DRC) in order to evaluate trends
Neonatal mortality rates overall and by year, n/N (rate/1000)
Total Africa South Asia Central America
Zambia/Kenya DRC India Pakistan Guatemala
2010–2018,
All Clusters
6088/463,922
(13.1)
1193/128,580
(9.3)
325/27,300
(11.9)
1721/168,570
(10.2)
1941/70,123
(27.7)
908/69,349
(13.1)
2010–2018, Ongoing 
 Clustersa
4884/382,635
(12.8)
1193/128,580
(9.3)
325/27,300
(11.9)
1269/130,297
(9.7)
1379/46,452
(29.7)
718/50,006
(14.4)
2010 670/44,605
(15.0)
205/15,302
(13.4)
– 217/18,394
(11.8)
172/6409
(26.8)
76/4500
(16.9)
2011 610/45,772
(13.3)
138/15,699
(8.8)
– 192/18,439
(10.4)
206/6583
(31.3)
74/5051
(14.7)
2012 550/44,032
(12.5)
134/14,702
(9.1)
– 191/18,370
(10.4)
165/5818
(28.4)
60/5142
(11.7)
2013 573/42,152
(13.6)
136/14,308
(9.5)
– 195/17,241
(11.3)
165/4963
(33.2)
77/5640
(13.7)
2014 539/42,301
(12.7)
114/13,608
(8.4)
76/5263
(14.4)
115/12,751
(9.0)
129/4876
(26.5)
105/5803
(18.1)
2015 498/42,431
(11.7)
121/13,981
(8.7)
56/5239
(10.7)
104/12,833
(8.1)
132/4398
(30.0)
85/5980
(14.2)
2016 534/41,912
(12.7)
142/13,882
(10.2)
57/5401
(10.6)
98/11,775
(8.3)
138/4421
(31.2)
99/6433
(15.4)
2017 492/40,820
(12.1)
112/13,616
(8.2)
76/5842
(13.0)
93/10,868
(8.6)
144/4525
(31.8)
67/5969
(11.2)
2018 418/38,610
(10.8)
91/13,482
(6.7)
60/5555
(10.8)
64/9626
(6.6)
128/4459
(28.7)
75/5488
(13.7)
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and Guatemala. Except for Pakistan, ≥ 2500  g neonatal 
mortality was higher in infants who were not placed on 
mother’s chest after delivery. Furthermore, in the African 
sites, the risk of ≥ 2500  g neonatal mortality was higher 
for multiple births compared to singletons.
Discussion
We examined neonatal mortality in seven sites in six 
countries over the last 9 years and explored the NMR and 
its risk factors in babies born alive with a birth weight 
of ≥ 2500  g. Across all sites, ≥ 2500  g babies accounted 
for 85% of the live-born babies and 45.4% of the neonatal 
deaths. The NMR for these babies averaged 13.1 per 1000 
live births across the sites from 2010 to 2018.
The Pakistan site had the highest ≥ 2500 g NMR at 29.7 
per 1000 livebirths and the Kenyan/Zambian sites the 
lowest at 9.3/1000. We found that the ≥ 2500 g neonatal 
mortality rates declined over the last nine-year period 
for the Indian and Kenyan/Zambian sites but not in Paki-
stan and Guatemala where no remarkable changes in 
the ≥ 2500 g NMRs were observed.
Maternal factors generally associated with increased 
risk of ≥ 2500  g neonatal mortality were older or 
younger ages, no formal education, nulliparity or a 
parity of ≥ 3, hypertensive disorders of pregnancy, 
obstructed labor, a history of previous stillbirths, and 
maternal death. However, other risks varied across 
the sites. Lack of adequate ANC visits or less care has 
been documented as a risk factor for poor pregnancy 
outcomes [11]. However, the number of ANC visits 
required to reduce risk remains in question. The WHO 
for many years supported a recommendation of at least 
four visits in resource-limited countries. However, 
these guidelines were revised recently and now WHO 
recommends at least eight ANC visits to achieve bet-
ter fetal and maternal outcomes [11]. We also found a 
higher risk of ≥ 2500  g neonatal mortality associated 
with reduced ANC visits during pregnancy at some 
sites. Maternal co-morbidities such as those found in 
this study can adversely affect the pregnancy outcomes 
and many are not sufficiently addressed in low-resource 
settings. Severe postpartum hemorrhage, hyperten-
sive disease and unplanned hospitalization were com-
mon risk factors for ≥ 2500 g neonatal mortality for all 
the participating sites. The literature suggests that in 
case of maternal illness or death, the chances of sur-
vival for a newborn is decreased. Babies whose moth-
ers are severely ill may be deprived of care such as 
2010 2011 2012 2013 2014 2015 2016 2017 2018
Year
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breastfeeding and skin to skin contact which may result 
in an increased risk of morbidity and mortality [12].
An estimated 10–15% of pregnancies will have com-
plications and might need a cesarean section or some 
other kind of assistance to facilitate delivery. In our 
study, ≥ 2500  g NMR was higher among those with 
vacuum and forceps assisted deliveries as compared 
to vaginal delivery in most sites. If timely intervention 
in the form of a cesarean section is not carried out for 
mothers for certain complications, the risk of mortality 
increases for the fetus, mother and newborn [13, 14]. 
With emphasis on facility delivery and skilled attend-
ance at birth, more women in low-resource countries 
are opting for delivery at a hospital, clinic or a health 
center. Our results show that as compared to a hospi-
tal delivery, the risk for ≥ 2500  g mortality was less in 
babies who were born in a clinic or a health center in 
Zambia/Kenya, DRC and India but not for Pakistan 
and Guatemala. We do not know the reasons for why 
women or their care- givers chose a particular location 
for delivery, but it seems likely that more women with 
pregnancy complications deliver in hospitals in Zam-
bia/Kenya and India, but perhaps less so in Pakistan 
and Guatemala. Home delivery was associated with an 
increased risk of ≥ 2500 g NMR only in the Indian sites.
For all sites except DRC, the ≥ 2500  g NMR risk was 
significantly higher among babies born preterm. Risk of 
NMR was also higher for multiple births in the African 
sites, male gender, those with congenital anomalies and 
those who were hospitalized at any time before 28 days 
of life. In high-income countries, almost all babies who 
are born with a birthweight of ≥ 2500 g survive, and the 
causes of mortality are different from those observed 
in low-income countries. In a countrywide study from 
the United States, sudden unexpected death of infants 
was the most common cause of infant mortality among 
infants born full term [15]. In contrast, common causes 
of ≥ 2500 g neonatal mortality in LMICs are prematurity, 
asphyxia and sepsis [5, 6].
The reported proportion with congenital anomalies 
in our sites was lower than reported from high- income 
countries, likely due to the low rates of X-rays, ultrasound 
and autopsies in these regions. Our results also show a 
higher risk of ≥ 2500 g neonatal mortality among babies 
born with congenital abnormalities at all the sites. Many 
anomalies cannot be treated in low-resource settings and 
that factor may account for some of the mortality associ-
ated with anomalies.
Table 3 Relative risk of neonatal death (< 28 day) by Global Network region and maternal characteristics for infants born 
alive and ≥ 2500 g, 2010–2018
a Relative risks (RR) and 95% confidence intervals from log-binomial models with generalized estimating equations to account for the correlation of outcomes within 
cluster. Neonatal mortality is modeled for each factor independently, accounting for site and the interaction of factor and site. Presented RR (95% CI) are for the 
interaction of factor and site to capture site-specific RRs
b Variable added to MNH forms in 2014
Adjusted RR for Neonatal Mortality for infants ≥ 2500 g (95% CI)a
Africa South Asia Central America
Zambia/Kenya DRC India Pakistan Guatemala
Delivery Location
 Hospital Ref Ref Ref Ref Ref
 Clinic/Health Center 0.58 (0.38, 0.89) 0.43 (0.29, 0.64) 0.80 (0.71, 0.91) 0.95 (0.81, 1.11) 0.84 (0.51, 1.39)
 Home/Other 0.66 (0.40, 1.09) 0.49 (0.32, 0.75) 1.35 (1.04, 1.76) 0.69 (0.61, 0.79) 1.07 (0.93, 1.24)
Delivery Mode
 Vaginal delivery Ref Ref Ref Ref Ref
 Assisted vacuum/forceps 4.50 (2.69, 7.53) 9.01 (3.15, 25.75) 4.82 (3.28, 7.07) 1.83 (1.53, 2.20) 2.38 (0.30, 19.11)
 C‑section 4.32 (3.36, 5.55) 6.98 (4.16, 11.70) 1.10 (0.98, 1.23) 1.32 (1.14, 1.52) 1.08 (0.95, 1.22)
Obstructed/prolonged labor/failure 
to progress
7.04 (5.48, 9.04) 15.49 (11.19, 21.44) 2.89 (2.23, 3.73) 2.71 (2.36, 3.10) 2.40 (2.09, 2.75)
Severe antepartum hemorrhage 4.80 (3.03, 7.61) 16.30 (8.70, 30.54) 4.23 (2.75, 6.52) 3.46 (2.89, 4.15) 1.90 (0.95, 3.79)
Severe postpartum hemorrhage 3.24 (2.41, 4.34) 6.94 (4.07, 11.84) 2.83 (1.78, 4.52) 2.05 (1.79, 2.34) 1.62 (1.14, 2.30)
Severe  infectionb 9.88 (6.13, 15.93) 12.07 (7.00, 20.80) 3.28 (1.32, 8.14) 2.99 (2.09, 4.28) 1.72 (0.91, 3.25)
Unplanned  hospitalizationb 8.56 (6.30, 11.63) 6.90 (4.24, 11.24) 2.85 (2.22, 3.66) 3.76 (2.00, 7.07) 2.84 (2.35, 3.44)
Abnormal fetal presentation 6.01 (4.69, 7.69) 8.12 (3.47, 19.01) 1.73 (1.30, 2.31) 2.74 (2.32, 3.23) 2.43 (1.72, 3.43)
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Resuscitation at birth, most likely due to pre-deliv-
ery asphyxia, was strongly associated with mortality 
at all sites. Infant hospitalization was also associated 
with ≥ 2500 g neonatal mortality at all sites.
Perinatal outcomes in twin or higher order multiple 
births, especially in resource-poor countries, are gen-
erally compromised. Our results also show a higher 
risk of mortality in twin births even with a birth weight 
of ≥ 2500  g. Maternal risk factors such as death, blood 
transfusion, intensive care unit admission or hysterec-
tomy are higher in twin pregnancies as compared to sin-
gleton pregnancies [16].
The risk of ≥ 2500  g neonatal mortality was high for 
babies who were not put on mothers’ chest after deliv-
ery. Whether this was causal or could be explained 
by the fact that sick newborns were not placed on the 
mother’s chest, since they were receiving medical care, 
is unknown. In general, skin-to-skin contact after birth 
helps to maintain temperature, helps initiate early breast-
feeding and promotes infant and maternal bonding [17].
This study had a number of strengths and some weak-
nesses. Among the strengths are the large sample size, 
multiple sites, prospective data collection and standard 
data collection protocols used across the sites. Weak-
nesses include the inability of some sites to collect all the 
data required. For example, data on anemia were incon-
sistently collected across the sites and were not analyzed 
for their association with ≥ 2500  g neonatal mortality. 
Blood pressure measurements were also not made con-
sistently across the sites and the lack of measurements, 
especially in the DRC may account for the very high rela-
tive risk for hypertension reported from that site. Report-
ing of congenital anomalies was generally based only 
on external observation and was likely not consistently 
determined across the sites. Also, a small number of the 
birthweights were estimated.
Conclusions
In summary, babies who were born with a birth weight 
of ≥ 2500  g accounted for 45% of all neonatal deaths 
across the Global Network. The NMR for these babies 
was highest for the Pakistan site and was lowest for the 
Zambian/Kenyan sites. A declining NMR was observed 
for Zambia/Kenya and India sites. In the Pakistan and 
Guatemala sites, the rates remained unchanged over 
the last nine years. The mortality risks in infants born 
at ≥ 2500 g were related to maternal, delivery and new-
born characteristics. The NMR for those infants was 
13.1 per 1000 live births, significantly higher than rates 
seen in high-income countries. The NMR and decline 
in mortality were not consistent across the sites. Even 
among infants ≥ 2500  g, lower gestational age and 
birthweight were largely associated with increased 
Table 5 Relative risk of neonatal death (< 28 day) by Global Network region and delivery characteristics for infants born 
alive and ≥ 2500 g, 2010–2018
a Relative risks (RR) and 95% confidence intervals from log-binomial models with generalized estimating equations to account for the correlation of outcomes within 
cluster. Neonatal mortality is modeled for each factor independently, accounting for site and the interaction of factor and site. Presented RR (95% CI) are for the 
interaction of factor and site to capture site-specific RRs
Adjusted RR for Neonatal Mortality for infants ≥ 2500 g (95% CI)a
Africa South Asia Central America
Zambia/Kenya DRC India Pakistan Guatemala
Delivery Location
 Hospital Ref Ref Ref Ref Ref
 Clinic/Health Center 0.58 (0.38, 0.89) 0.43 (0.29, 0.64) 0.80 (0.71, 0.91) 0.95 (0.81, 1.11) 0.84 (0.51, 1.39)
 Home/Other 0.66 (0.40, 1.09) 0.49 (0.32, 0.75) 1.35 (1.04, 1.76) 0.69 (0.61, 0.79) 1.07 (0.93, 1.24)
Delivery Mode
 Vaginal delivery Ref Ref Ref Ref Ref
 Assisted vacuum/forceps 4.50 (2.69, 7.53) 9.01 (3.15, 25.75) 4.82 (3.28, 7.07) 1.83 (1.53, 2.20) 2.38 (0.30, 19.11)
 C‑section 4.32 (3.36, 5.55) 6.98 (4.16, 11.70) 1.10 (0.98, 1.23) 1.32 (1.14, 1.52) 1.08 (0.95, 1.22)
Obstructed/prolonged labor/failure 
to progress
7.04 (5.48, 9.04) 15.49 (11.19, 21.44) 2.89 (2.23, 3.73) 2.71 (2.36, 3.10) 2.40 (2.09, 2.75)
Severe antepartum hemorrhage 4.80 (3.03, 7.61) 16.30 (8.70, 30.54) 4.23 (2.75, 6.52) 3.46 (2.89, 4.15) 1.90 (0.95, 3.79)
Severe postpartum hemorrhage 3.24 (2.41, 4.34) 6.94 (4.07, 11.84) 2.83 (1.78, 4.52) 2.05 (1.79, 2.34) 1.62 (1.14, 2.30)
Severe  infectionb 9.88 (6.13, 15.93) 12.07 (7.00, 20.80) 3.28 (1.32, 8.14) 2.99 (2.09, 4.28) 1.72 (0.91, 3.25)
Unplanned  hospitalizationb 8.56 (6.30, 11.63) 6.90 (4.24, 11.24) 2.85 (2.22, 3.66) 3.76 (2.00, 7.07) 2.84 (2.35, 3.44)
Abnormal fetal presentation 6.01 (4.69, 7.69) 8.12 (3.47, 19.01) 1.73 (1.30, 2.31) 2.74 (2.32, 3.23) 2.43 (1.72, 3.43)
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NMR. Since many of the deaths in infants with birth-
weight ≥ 2500  g should be preventable, attention to 
preventing mortality in these infants should have an 
important impact on overall NMR.
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Table 7 Relative risk of neonatal death (< 28 day) by Global Network Region and newborn characteristics for infants born 
alive and ≥ 2500 g, 2010–2018
a Relative risks (RR) and 95% confidence intervals from log-binomial models with generalized estimating equations to account for the correlation of outcomes within 
cluster. Neonatal mortality is modeled for each factor independently, accounting for site and the interaction of factor and site. Presented RR (95% CI) are for the 
interaction of factor and site to capture site-specific RRs
Adjusted RR for neonatal mortality for infants ≥ 2500 g (95% CI)a
Africa South Asia Central America
Zambia/Kenya DRC India Pakistan Guatemala
Preterm 2.02 (1.57, 2.59) 1.33 (0.99, 1.79) 1.62 (1.33, 1.98) 3.09 (2.84, 3.36) 1.35 (1.16, 1.56)
Birthweight
 2500–2700 g 2.55 (1.96, 3.33) 1.14 (0.84, 1.55) 1.43 (1.17, 1.75) 3.95 (3.48, 4.49) 1.06 (0.79, 1.43)
 2701–3000 g 1.61 (1.36, 1.90) 1.08 (0.80, 1.46) 1.12 (0.94, 1.34) 2.53 (2.16, 2.96) 1.16 (0.98, 1.38)
 3001–3500 g Ref Ref Ref Ref Ref
 > 3500 g 1.57 (1.29, 1.92) 1.50 (1.02, 2.21) 1.12 (0.75, 1.66) 1.05 (0.82, 1.33) 1.71 (1.41, 2.07)
Not placed on mother’s chest after delivery 2.44 (1.93, 3.09) 3.43 (1.75, 6.72) 3.18 (2.54, 4.00) 1.18 (0.95, 1.47) 1.87 (1.62, 2.17)
Multiple Birth 3.51 (2.67, 4.60) 3.40 (2.00, 5.76) 1.45 (0.74, 2.83) 0.93 (0.51, 1.70) 1.85 (0.91, 3.80)
Gender
 Male 1.25 (1.06, 1.47) 1.34 (1.08, 1.67) 1.33 (1.19, 1.48) 1.20 (1.08, 1.34) 1.29 (1.18, 1.41)
 Female Ref Ref Ref Ref Ref
Congenital anomaly 36.51 (20.67, 64.46) 49.79 (6.71, 369.67) 101.00 (75.32, 135.43) 9.66 (7.12, 13.10) 21.93 (15.86, 30.32)
Hospitalization 10.01 (4.39, 22.82) 38.70 (20.80, 71.99) 66.43 (45.04, 97.97) 57.27 (46.58, 70.41) 25.96 (18.67, 36.12)
Resuscitation with bag and mask, N (%) 18.55 (14.38, 23.92) 48.24 (36.86, 63.14) 29.60 (22.37, 39.16) 6.57 (5.80, 7.45) 13.29 (10.87, 16.26)
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